{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:35:47Z","timestamp":1783132547123,"version":"3.54.6"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jasc.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:42:34Z","timestamp":1611920554000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience"],"prefix":"10.1016","volume":"10","author":[{"given":"Regina M.","family":"Plummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-9055","authenticated-orcid":false,"given":"Sarah","family":"Kelting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashna","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"O\u2019Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0994-8933","authenticated-orcid":false,"given":"Katie","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-2798","authenticated-orcid":false,"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/17441692.2015.1134613","article-title":"A global research synthesis of HIV and STI biobehavioural risks in female-to-male transgender adults","volume":"11","author":"Reisner","year":"2016","journal-title":"Glob Public Health"},{"key":"10.1016\/j.jasc.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2458-12-292","article-title":"High heterogeneity of HIV-related sexual risk among transgender people in Ontario, Canada: a province-wide respondent-driven sampling survey","volume":"12","author":"Bauer","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jasc.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/AOG.0b013e31823ed1c1","article-title":"Health care for transgender individuals","volume":"118","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jasc.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1177\/1049732317725513","article-title":"\u201cIt can promote an existential crisis\u201d: factors influencing papanicolaou test acceptability and utilization among transmasculine individuals","volume":"27","author":"Peitzmeier","year":"2017","journal-title":"Qual Health Res"},{"key":"10.1016\/j.jasc.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cyt.12525","article-title":"Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia","volume":"29","author":"Adkins","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self-versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cncy.22259","article-title":"Cytomorphologic findings of cervical Papanicolaou smears from female-to-male transgender patients on testosterone therapy","volume":"128","author":"Williams","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2021.01.004_bib10","first-page":"1454","article-title":"Expressing observations from electronic medical record flowsheets in an i2b2 based clinical data repository to support research and quality improvement","volume":"2011","author":"Waitman","year":"2011","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.jasc.2021.01.004_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jamia.2009.000893","article-title":"Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)","volume":"17","author":"Murphy","year":"2010","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jasc.2021.01.004_bib12","series-title":"The Bethesda System for Reporting Cervical Cytology, Definitions, Criteria, and Explanatory Notes","year":"2004"},{"key":"10.1016\/j.jasc.2021.01.004_bib13","series-title":"The Bethesda System for Reporting Cervical Cytology, Definitions, Criteria, and Explanatory Notes","article-title":"Non-neoplastic findings","author":"Kurtycz","year":"2015"},{"key":"10.1016\/j.jasc.2021.01.004_bib14","series-title":"The Bethesda System for Reporting Cervical Cytology, Definitions, Criteria, and Explanatory Notes","article-title":"Specimen adequacy","author":"Birdsong","year":"2015"},{"key":"10.1016\/j.jasc.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2013.01.010","article-title":"Clinical determinants and smear characteristics of unsatisfactory conventional cervicovaginal smears","volume":"168","author":"Gupta","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jasc.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cncy.20110","article-title":"Should adequacy criteria in cervicovaginal cytology be modified after radiotherapy, chemotherapy, or hysterectomy?","volume":"118","author":"Lu","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2021.01.004_bib17","first-page":"505","article-title":"Cellular constitution of autocyte PREP cervicovaginal samples with biopsy-confirmed HSIL","volume":"44","author":"Geyer","year":"2000","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000326576","article-title":"Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology","volume":"47","author":"Studeman","year":"2003","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6604324","article-title":"Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial","volume":"98","author":"Sargent","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jasc.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/jir342","article-title":"Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States - National Health and Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?","volume":"204","author":"Dunne","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jasc.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jasc.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006","volume":"204","author":"Hariri","year":"2011","journal-title":"J Infect Dis"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294521000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:46:26Z","timestamp":1761979586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294521000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213294521000107"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2021.01.004","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}